Nucleo Research

Founded by Angelica Iacovelli and Luca Pegolotti — former researchers at Stanford and Apple Health AI — Nucleo is an AI platform for oncology that turns routine CT scans into automated body-composition analysis, tumour detection and classification, and organ segmentation, with a long-term goal of building an AI 'world model' that predicts disease progression and treatment response.

A Y Combinator-backed company that has raised $4M to date, Nucleo already works with hospitals including Stanford Hospital, Cedars-Sinai, UCI Health and Weill Cornell to speed up radiologists' and oncologists' clinical workflows.